ARCHIVES

Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards

This article is from The Cancer Letter archive.

Vol. 09 No. 41 | October 28, 1983

Download PDF Visit The Full Archive

Related Articles

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

DeVita, Moertel Debate Timing Of Levamisole Update

February 16, 1990